UPLOAD Filing
Moleculin Biotech, Inc.
Date: April 2, 2026 · CIK: 0001659617 · Accession: 0000000000-26-003361
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294686
Letter
Re: Moleculin Biotech, Inc. Registration Statement on Form S-3 Filed March 27, 2026 File No. 333-294686 Dear Walter V. Klemp:
April 2, 2026
Walter V. Klemp Chief Executive Officer Moleculin Biotech, Inc. 5300 Memorial Drive Suite 950 Houston, TX 77007
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Johnathan C. Duncan, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 2, 2026 Walter V. Klemp Chief Executive Officer Moleculin Biotech, Inc. 5300 Memorial Drive Suite 950 Houston, TX 77007 Re: Moleculin Biotech, Inc. Registration Statement on Form S-3 Filed March 27, 2026 File No. 333-294686 Dear Walter V. Klemp: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Johnathan C. Duncan, Esq. </TEXT> </DOCUMENT>